Anti-pneumocystis activities of aromatic diamidoxime prodrugs

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 666-674

  Hall, James Edwin ^a,b   Kerrigan, John E ^b,d   Ramachandran, Kishore ^b   Bender, Brendan C ^b   Stanko, Jason P ^b   Jones, Susan K ^b   Patrick, Donald A ^b   Tidwell, Richard R ^b,c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDOXIME DERIVATIVE; BIS(BENZAMIDOXINE) DERIVATIVE; PENTAMIDINE; PRODRUG; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; HYPOTENSION; LIVER HOMOGENATE; MALE; NONHUMAN; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; RAT;

EID: 0031919696     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.666     Document Type: Article

References (54)

1. Andrewes, C. H., H. King, and J. Walker. 1946. Experimental chemotherapy of typhus. Anti-rickettsial action of p-sulphonamidobenzamidine and related compounds. Proc. R. Soc. Lond. Ser. B 133:20-62.
2. Apted, F. I. C. 1980. Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the Eastern hemisphere. Pharmacol. Ther. 11: 391-413.
3. Bell, C. A., M. Cory, T. A. Fairley, J. E. Hall, and R. R. Tidwell. 1991. Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrob. Agents Chemother. 35:1099-1107.
4. Bell, C. A., C. C. Dykstra, N. A. Naiman, M. Cory, T. A. Fairley, and R. R. Tidwell. 1993. Structure-activity studies of dicationically substituted bisbenzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition. Antimicrob. Agents Chemother. 37:2668-2673.
5. Bell, C. A., J. E. Hall, D. E. Kyle, M. Grogl, K. A. Ohemeng, M. A. Allen, and R. R. Tidwell. 1990. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob. Agents Chemother. 34:1381-1386.
6. Berger, B. J. 1992. Ph.D. dissertation. University of North Carolina, Chapel Hill.
7. Berger, B. J., R. J. Lombardy, G. D. Marbury, C. A. Bell, C. C. Dykstra, J. E. Hall, and R. R. Tidwell. 1990. Metabolic N-hydroxylation of pentamidine in vitro. Antimicrob. Agents Chemother. 34:1678-1684.
8. Berger, B. J., N. A. Naiman, J. E. Hall, J. Peggins, T. G. Brewer, and R. R. Tidwell. 1992. Primary and secondary metabolism of pentamidine by rats. Antimicrob. Agents Chemother. 36:1825-1831.
9. Berger, B. J., V. V. Reddy, S. T. Le, R. J. Lombardy, J. E. Hall, and R. R. Tidwell. 1991. Hydroxylation of pentamidine by rat liver microsomes. J. Pharmacol. Exp. Ther. 256:883-889.
10. Blagburn, B. L., C. A. Sundermann, D. S. Lindsay, J. E. Hall, and R. R. Tidwell. 1991. Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR) BR Swiss mice by polyether ionophores and aromatic amidines. Antimicrob. Agents Chemother. 35:1520-1523.
11. Bowling, M. C., I. M. Smith, and S. L. Wescott. 1973. A rapid staining procedure for Pneumocystis carinii. Am. J. Med. Technol. 39(7):267-268.
12. Boykin, D. W. 1996. Unpublished data.
13. Boykin, D. W., A. Kumar, J. E. Hall, B. C. Bender, and R. R. Tidwell. 1996. Anti-Pmumocystis activity of bis-amidoximes and bis-O-alkylamidoximes prodrugs. Bioorg. Med. Chem. Lett. 6:3017-3020.
14. Boykin, D. W., A. Kumar, J. Spychala, M. Zhou, R. J. Lombardy, W. D. Wilson, C. C. Dykstra, S. K. Jones, J. E. Hall, R. R. Tidwell, C. Laughton, and S. Neidle. 1995. Dicationic diarylfurans as anti-Pneumocystis carinii agents. J. Med. Chem. 38:912-916.
15. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
16. 14C-pentamidine and identification of metabolites in urine using liquid chromatography-tandem mass spectrometry. Pharmacol. Toxicol. 77:114-120.
17. Buu-Hoi, N. P., M. Welsch, N. D. Xuong, and K. U. Thang. 1954. Une nouvelle famille de composes tuberculostatiques: les amidoximes. Experientia 10:169.
18. Chabrier, P., G. Maillard, and A. Quevauviller. 1956. Nouvelles recherches sur les rapports entre structure chimique, activite antibacterienne, antifungique et toxicite, dans la serie des esters de l'acide dithiocarbamique N-disubstitue. Ann. Pharm. Fr. 14:720-728.
19. Clement, B. June 1994. German patent DE 4321444A1.
20. Clement, B., M. Immel, and W. Raether. 1992. Metabolic N-hydroxylation of diminazine in vitro. Arzneim.-Forsch. 42:1497-1504.
21. Clement, B., M. Immel, R. Terlinden, and F. Wingen. 1992. Reduction of amidoxime derivatives to pentamidine in vivo. Arch. Pharm. 325:61-62.
22. Clement, B., and F. Jung. 1994. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Drug Metab. Dispos. 22:486-497.
23. Clement, B., and W. Raether. 1985. Amidoximes of pentamidine: synthesis, trypanocidal and leishmaniacidal activity. Arzneim.-Forsch. 35:1009-1014.
24. Drake, S., V. Lampasona, H. L. Nicks, and S. W. Schwarzmann. 1985. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Clin. Pharm. 4:507-516.
25. Dubovi, E. J., J. D. Geratz, S. R. Shaver, and R. R. Tidwell. 1981. Inhibition of respiratory syncytial virus-host cell interaction by mono-and diamidines. Antimicrob. Agents Chemother. 19:649-656.
26. Dubovi, E. J., J. D. Geratz, and R. R. Tidwell. 1980. Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane. Virology 103: 502-504.
27. Dykstra, C. C. 1996. Unpublished data.
28. Fuller, A. T., I. M. Tonkin, and J. Walker. 1945. Chemotherapeutic agents of the sulphone type. II. Sulphones related to benzamidine and benzylamine. J. Chem. Soc. 1945:633-637.
29. Geratz, J. D., M. C. F. Cheng, and R. R. Tidwell. 1975. New aromatic diamidines with central alpha-oxyalkane or alpha, omega-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein and thrombin and for the inhibition of the overall coagulation process. J. Med. Chem. 18:477-481.
30. Geratz, J. D., M. C. F. Cheng, and R. R. Tidwell. 1976. Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin and complement. J. Med. Chem. 19:634-639.
31. Geratz, J. D., K. B. Pryzwansky, J. H. Schwab, S. K. Anderle, and R. R. Tidwell. 1993. Modulation of local and systemic responses in streptococcal cell wall-induced inflammation of the air pouch by two anti-inflammatory bis-benzimidazoles and by cyclosporine A. Am. J. Pathol. 142:1227-1237.
32. Geratz, J. D., K. B. Pryzwansky, J. H. Schwab, S. K. Anderle, and R. R. Tidwell. 1988. Suppression of streptococcal cell wall-induced arthritis by a potent protease inhibitor, bis(5-amidino-2-benzimidazolyl)methane. Arthritis Rheum. 31:1156-1164.
33. Geratz, J. D., S. R. Shaver, and R. R. Tidwell. 1981. Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and high and low molecular weight urokinase and on urokinase-induced plasminogen activation. Thromb. Res. 24:73-83.
34. Geratz, J. D., F. M. Stevens, K. L. Polakoski, R. F. Parrish, and R. R. Tidwell. 1979. Amidino-substituted aromatic heterocycles as probes of the specificity pocket of trypsin-like proteases. Arch. Biochem. Biophys. 197: 551-559.
35. Geratz, J. D., R. R. Tidwell, K. M. Brinkhous, S. F. Mohammad, O. Dann, and H. Loewe. 1978. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds. Thromb. Haemostasis 39:411-425.
36. Geratz, J. D., R. R. Tidwell, R. J. Lombardy, J. H. Schwab, S. K. Anderle, and K. B. Pryzwansky. 1991. Streptococcal cell wall-induced systemic disease. Beneficial effects of trans-bis(5-amidino-2-benzimidazolyl)ethene, a novel macrophage-directed antiinflammatory agent. Am. J. Pathol. 139:921-931.
37. Geratz, J. D., R. R. Tidwell, J. H. Schwab, S. K. Anderle, and K. B. Pryzwansky. 1990. Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM). Am. J. Pathol. 136:909-921.
38. Goa, K. L., and D. M. Campoli-Richards. 1987. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs 33:242-258.
39. Hall, J. E. 1996. Unpublished data.
40. Jones, S. K., J. E. Hall, M. A. Allen, S. D. Morrison, K. A. Ohemeng, V. V. Reddy, J. D. Geratz, and R. R. Tidwell. 1990. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 34:1026-1030.
41. King, H., E. Lourie, and W. Yorke. 1938. Studies in chemotherapy. XIX. Further report on new trypanocidal substances. Ann. Trop. Med. Parasitol. 32:177-192.
42. Lamb, I. D., and A. C. White. 1939. Some amidines and amidoximes with trypanocidal activity. J. Chem. Soc. 1939:1253-1257.
43. Lindsay, D. S., B. L. Blagburn, J. E. Hall, and R. R. Tidwell. 1991. Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrob. Agents Chemother. 35:1914-1916.
44. Lourie, E. M., and W. Yorke. 1939. Studies in chemotherapy. XXI. The trypanocidal action of certain aromatic diamidines. Ann. Trop. Med. Parasitol. 33:289-304.
45. Perfect, J. R. 1996. Unpublished data.
46. Spychala, J., D. W. Boykin, W. D. Wilson, M. Zhao, R. R. Tidwell, C. C. Dykstra, J. E. Hall, S. K. Jones, and R. F. Schinazi. 1994. Synthesis of dicationic diaryltriazines as nucleic acid binding agents. Eur. J. Med. Chem. 29:363-367.
47. Tidwell, R. R. 1996. Unpublished data.
48. Tidwell, R. R., and C. A. Bell. 1993. Pentamidine and related compounds in the treatment of Pneumocystis carinii infection, p. 561-583. In P. Walzer (ed.), Pneumocystis carinii, 2nd ed. Marcel Dekker, New York, N.Y.
49. Tidwell, R. R., J. D. Geratz, W. A. Clyde, Jr., K. U. Rosenthal, and E. J. Dubovi. 1984. Suppression of respiratory syncytial virus infection in cotton rats by bis(5-amidino-2-benzimidazolyl)methane. Antimicrob. Agents Chemother. 26:591-593.
50. Tidwell, R. R., S. K. Jones, J. D. Geratz, K. A. Ohemeng, M. Cory, and J. E. Hall. 1990. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J. Med. Chem. 33:1252-1257.
51. Tidwell, R. R., S. K. Jones, N. A. Naiman, L. C. Berger, W. B. Brake, C. C. Dykstra, and J. E. Hall. 1993. Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 37:1713-1716.
52. van Breemen, R. B., O. Jiang, J. E. Hall, T. G. Brewer, and R. R. Tidwell. 1995. Fast atom bombardment tandem mass spectrometry of the anti-parasitic agent pentamidine and its oxygenated metabolites. Drug Metab. Dispos. 30:549-556.
53. Vonderfecht, S. L., R. L. Miskuff, S. BiWee, S. Sato, R. R. Tidwell, J. D. Geratz, and R. H. Yolken. 1988. Protease inhibitors suppress the in vitro and in vivo replication of rotavirus. J. Clin. Invest. 82:2011-2016.
54. Weller, T., L. Alig, M. Beresini, B. Blackburn, S. Bunting, P. Hadvary, M. H. Muller, D. Knopp, B. Level-Trafit, M. T. Lipari, N. B. Modi, M. Muller, C. J. Refino, M. Schmitt, P. Schonholzer, S. Weiss, and B. Steiner. 1996. Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines. J. Med. Chem. 39:3139-3147.